HDAC6 is upregulated in corneal diseases and causes ENKD1 deacetylation at lysine 98. Deacetylation of ENKD1 blocks its ...

The RESTORE VISION scientific team has identified seven rare ocular conditions that impact the cornea and the rest of the ocular surface. "With a comprehensive approach, we aim to restore the ...

Pantheon Vision has signed a deal with Eyedeal Medical to advance the manufacturing of its corneal implants for treating ...

Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Innovative Cell Therapy for Corneal Endothelial Disease ...

Pakistan: Losartan, a widely used angiotensin II receptor blocker for hypertension, has recently been recognized for its ...

Alcon acquired a majority interest in Aurion Biotech, a clinical-stage company developing advanced cell therapies to treat eye diseases. Terms of the deal weren't disclosed.

The global artificial cornea and corneal implant market size was US$ 381.5 million in 2021. The global artificial cornea and corneal implant market is forecast to grow to US$ 701.4 million by 2030 by ...

EyeYon Medical, a global leader in innovative corneal implant solutions, is proud to announce that Dr. Ofer Daphna, the ...

Aurion is developing AURN001, a clinical-stage allogeneic cell therapy asset, for corneal edema secondary to corneal ...

“Alcon is dedicated to developing and delivering innovative treatments for global unmet needs in eye care, including vision-threatening corneal endothelial disease, which affects millions of ...